Todd Miller, PhD, and Nicole Traphagen in the Miller laboratory (IMAGE)

Dartmouth Health

Todd Miller, PhD, and Nicole Traphagen in the Miller laboratory

Caption

Todd Miller, PhD (left), and Nicole Traphagen, a PhD candidate in the Miller Laboratory, have found a method for long-term control of drug-resistant breast cancer growth in preclinical models by switching between estrogen and anti-estrogen therapies. The strategy is now in human clinical trials at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center.

Credit

Mark Washburn

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.